Literature DB >> 17279540

Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1.

Yanling Wang1, Joel S F Greenwood, Maria Elisa Calcagnotto, Heidi E Kirsch, Nicholas M Barbaro, Scott C Baraban.   

Abstract

OBJECTIVE: To identify brain regions, cell types, or both that generate abnormal electrical discharge in tuberous sclerosis complex (TSC). Here we examined excitatory and inhibitory synaptic currents in human tissue samples obtained from a TSC patient with no discernible cortical tubers and acute neocortical brain slices from a mouse featuring synapsin-driven conditional deletion of a TSC1 gene. These studies were designed to assess whether TSC gene inactivation alters excitability.
METHODS: We used visualized patch-clamp (human and mouse) and extracellular field (mouse) recordings. Additional mice were processed for immunohistochemistry or Western blot analysis.
RESULTS: Detailed anatomic studies in brain tissue sections from synapsin-TSC1 conditional knock-out mice failed to uncover gross anatomic defects, loss of lamination, or frank tuber formation. However, regions of abnormal and potentially activated neocortex were shown using antibodies to nonphosphorylated neurofilaments (SMI-311) and immediate early genes (c-Fos). Extracellular recordings from neocortical slices, examining synaptic activity in these regions, demonstrated clear differences in excitability between conditional knock-out and age-matched control mice. Whole-cell patch-clamp recordings demonstrated excitatory synaptic currents with strikingly long duration and epileptiform discharge patterns, similar to waveforms observed in our human tissue samples. These events were 1-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor mediated and were most prominent in neocortex. Normal-appearing inhibitory postsynaptic currents (human) and intrinsic neuronal firing patterns (mouse) were also recorded.
INTERPRETATION: This combination of human and mouse tissue studies suggests, for the first time, that synaptic excitation is altered in a direction that favors seizure generation in TSC brain tissue regardless of cortical tubers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17279540     DOI: 10.1002/ana.21058

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  53 in total

Review 1.  Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2007-08-28       Impact factor: 5.864

Review 2.  Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges.

Authors:  Romina Moavero; Caterina Cerminara; Paolo Curatolo
Journal:  Childs Nerv Syst       Date:  2010-04-01       Impact factor: 1.475

3.  Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin.

Authors:  Itzamarie Chévere-Torres; Jordan M Maki; Emanuela Santini; Eric Klann
Journal:  Neurobiol Dis       Date:  2011-07-30       Impact factor: 5.996

4.  Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex.

Authors:  Carlos Cepeda; Véronique M André; Jason S Hauptman; Irene Yamazaki; My N Huynh; Julia W Chang; Jane Y Chen; Robin S Fisher; Harry V Vinters; Michael S Levine; Gary W Mathern
Journal:  Neurobiol Dis       Date:  2011-08-23       Impact factor: 5.996

Review 5.  Tuberous sclerosis complex: a brave new world?

Authors:  Kevin C Ess
Journal:  Curr Opin Neurol       Date:  2010-04       Impact factor: 5.710

6.  Brain MR spectroscopic abnormalities in "MRI-negative" tuberous sclerosis complex patients.

Authors:  William E Wu; Ivan I Kirov; Assaf Tal; James S Babb; Sarah Milla; Joseph Oved; Howard L Weiner; Orrin Devinsky; Oded Gonen
Journal:  Epilepsy Behav       Date:  2013-03-22       Impact factor: 2.937

7.  Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis.

Authors:  Umut Ozcan; Lale Ozcan; Erkan Yilmaz; Katrin Düvel; Mustafa Sahin; Brendan D Manning; Gökhan S Hotamisligil
Journal:  Mol Cell       Date:  2008-03-14       Impact factor: 17.970

8.  Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice.

Authors:  Jing Zhou; Jacqueline Blundell; Shiori Ogawa; Chang-Hyuk Kwon; Wei Zhang; Christopher Sinton; Craig M Powell; Luis F Parada
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

9.  Altering the trajectory of early postnatal cortical development can lead to structural and behavioural features of autism.

Authors:  Taylor Chomiak; Vikram Karnik; Edward Block; Bin Hu
Journal:  BMC Neurosci       Date:  2010-08-19       Impact factor: 3.288

10.  Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.

Authors:  Sharon W Way; James McKenna; Ulrike Mietzsch; R Michelle Reith; Henry Cheng-Ju Wu; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2009-01-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.